Provider review, September 2026

Aurelius Health Group Review

Aurelius names the medical group that actually prescribes, separately from its own brand, and prints a rival's price range in the same table as its own.

What Aurelius Health Group charges

Tirzepatide: $89 — the introductory first-month rate, printed as '$89 first month, then $199/month' — a first-month figure, not the recurring one, and the page states the recurring rate beside it. A separate 200-to-300 range on the same page is Aurelius's characterization of rival sellers, not its own price

Aurelius Health Group also sells 1 compound this site boards without publishing a price for it: NAD+.

Aurelius Health Group is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Aurelius Health Group

By Nora Castellan, Standards EditorUpdated September 2026

It names the prescribing layer

The terms of use name Aurelius Health, Inc. as the company behind the brand. Its HIPAA notice separately names OpenLoop Healthcare Partners PC and a California professional corporation in the same group as the prescribing side.

Splitting a consumer brand from the professional corporation that writes prescriptions is standard in telehealth and rarely disclosed this plainly. A reader can see which entity holds which role.

The chain stops short of the pharmacy. No page names the facility that fills an order, so the top of the arrangement is disclosed and the bottom is blank.

Two prices in one table, and only one is its own

The homepage comparison table sets Aurelius against a column it labels as one-time prescriptions with limited follow-up. That rival column carries a monthly cost range.

The range is Aurelius describing other sellers. It is not a price for anything Aurelius sells, and it is not treated as one here.

The layout invites the mistake. A reader skimming the table sees monthly figures in adjacent columns, and only one of them is a charge they could ever receive.

Its own figure is an introductory month

Aurelius states an introductory first-month rate and a higher recurring rate in the same sentence. Both are visible, which beats a headline promotion with the renewal buried.

The figure recorded here is the introductory one, and it is not what a buyer pays past the first month. Plan around the recurring rate instead.

The priced line is microdose tirzepatide. Its NAD+ line carries no figure at all, so the peptide on the menu is the one without a cost.

What it claims about charges and evidence

The site says full pricing is presented before any charge is made. That is a commitment a buyer can hold it to at checkout.

It also cites the published trials behind the outcome ranges it quotes, rather than presenting results as house knowledge. A citation is not proof, but it makes the claim checkable.

No page lists the states served, and no page describes lab work as covered by what it charges. Both stay open until intake.

Who it's for

Readers who want the prescribing professional corporation named separately from the brand.
Buyers who want the introductory rate and the recurring rate stated in the same breath.
Anyone who checks the trials behind an outcome claim.
Shoppers who read a comparison table closely enough to see whose price is whose.

Who should look elsewhere

Anyone likely to read the rival column in that table as an Aurelius price.
Readers shopping NAD+ on cost, because that line carries no figure.
Buyers who want the recurring rate as the headline rather than a first-month promotion.
People who need a published state list and a named dispensing pharmacy.

Strengths

Names the prescribing professional corporation separately from the brand company
States both the introductory rate and the recurring rate in the same sentence
Says full pricing is presented before any charge is made
Cites the published trials behind the outcome ranges it quotes

Trade-offs

Prints a competitor price range in the same table as its own, where a careless reader will merge them
Its recorded figure is an introductory month, not the rate most buyers will pay
Publishes no figure for the NAD+ line it also names
Publishes no state list and names no dispensing pharmacy

How we verified this

Read the terms of use for the operating company and the HIPAA notice for the prescribing entities, and recorded each name against its stated role.
Read the homepage comparison table column by column, and recorded which figure belongs to Aurelius and which is its characterization of other sellers.
Recorded the introductory rate and the recurring rate as the site states them, and noted that the introductory one is not the standing charge.
Checked the NAD+ line for a cost and recorded that it carries none.
Checked the public pages for a named dispensing pharmacy and a list of states served, and screened the operating company in the federal warning-letter record with a known-positive and a nonsense control.

A provider to compare Aurelius Health Group against

Trellis Vitality

Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.

Read the full Trellis Vitality review

Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Trellis Vitality

Frequently asked questions

Whose price is in the comparison table?

Both. One column is Aurelius, and the column beside it carries a range Aurelius attributes to other sellers. Only the Aurelius column is a charge you could actually receive.

Is the advertised rate the one I keep paying?

No. The site states an introductory first-month rate and a higher recurring rate in the same sentence. Plan around the recurring one, because that is the standing charge.

Who writes the prescription?

Aurelius names OpenLoop Healthcare Partners PC and a California professional corporation in the same group, disclosed on its HIPAA notice and kept distinct from the brand company.

What does NAD+ cost here?

Aurelius does not say. NAD+ is named on the menu without a figure, while its microdose tirzepatide line carries one. An NAD+ shopper leaves without a number.